Search Results for keywords:"scientific evidence"

The Environmental Protection Agency (EPA) has completed a final risk evaluation under the Toxic Substances Control Act (TSCA) for formaldehyde, finding that it poses an unreasonable risk to human health. This risk includes both non-cancer effects from short-term skin and inhalation exposure and cancer risks from long-term inhalation exposure. The EPA is required to initiate risk management actions to address these risks. The decision was made based on comprehensive scientific studies and evaluations.

The Environmental Protection Agency (EPA) has revised the air quality standards for sulfur dioxide (SO₂) to better protect the environment. The previous standard had a three-hour measurement period, but now it is an annual average over three years, limited to 10 parts per billion (ppb). The EPA decided to keep the existing standards for nitrogen oxides and particulate matter the same. This update comes after reviewing scientific evidence and public feedback to ensure the standards protect public wellness without being too strict.

The Federal Register notice from the Centers for Medicare & Medicaid Services is asking for nominations for the Medicare Evidence Development & Coverage Advisory Committee (MEDCAC). This committee provides advice on Medicare coverage policies by evaluating scientific evidence for medical treatments and technologies. Nominations must be submitted by February 17, 2025, and should include details like the nominee’s qualifications and lack of conflicts of interest. The committee wants to ensure diverse representation, so they are especially encouraging nominations from different backgrounds, including those from racial and ethnic groups, individuals with disabilities, and across the gender spectrum.

The Food and Drug Administration (FDA) is holding a virtual public workshop on February 25, 2025, focusing on developing scientific evidence for cell therapies and tissue-based products. The workshop aims to discuss the latest scientific developments, challenges, and best practices required for advancing cellular therapies, including stem cell products. Participants, including experts from research and academic fields, will delve into topics such as safety considerations, product quality, and risks involved in these therapies. Interested parties can register for the free event, and a recording will be made available online after the workshop.